Rank | Gene Set | Z-score |
---|---|---|
1 | polyketide metabolic process (GO:0030638) | 9.29033687 |
2 | doxorubicin metabolic process (GO:0044598) | 9.29033687 |
3 | daunorubicin metabolic process (GO:0044597) | 9.29033687 |
4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.20047915 |
5 | ribosomal small subunit biogenesis (GO:0042274) | 5.52477663 |
6 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.25892386 |
7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.10782412 |
8 | negative regulation of epidermis development (GO:0045683) | 5.08865537 |
9 | maintenance of protein location in nucleus (GO:0051457) | 5.01707529 |
10 | somite rostral/caudal axis specification (GO:0032525) | 4.87275847 |
11 | rRNA methylation (GO:0031167) | 4.82052929 |
12 | rRNA modification (GO:0000154) | 4.73542982 |
13 | regulation of mitochondrial translation (GO:0070129) | 4.73457697 |
14 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.70845694 |
15 | rRNA transcription (GO:0009303) | 4.70673802 |
16 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.66320124 |
17 | protein localization to kinetochore (GO:0034501) | 4.57647618 |
18 | protein maturation by protein folding (GO:0022417) | 4.53815011 |
19 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.47088241 |
20 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.45899216 |
21 | regulation of response to osmotic stress (GO:0047484) | 4.44057481 |
22 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.39042275 |
23 | ATP synthesis coupled proton transport (GO:0015986) | 4.39042275 |
24 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.35794209 |
25 | negative regulation of telomerase activity (GO:0051974) | 4.33265312 |
26 | formation of translation preinitiation complex (GO:0001731) | 4.14963470 |
27 | nucleobase-containing small molecule interconversion (GO:0015949) | 4.14889045 |
28 | quinone metabolic process (GO:1901661) | 4.13102497 |
29 | respiratory electron transport chain (GO:0022904) | 4.10666326 |
30 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.08723273 |
31 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.03706098 |
32 | histone H4-K12 acetylation (GO:0043983) | 4.03505826 |
33 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.03404199 |
34 | DNA replication checkpoint (GO:0000076) | 4.02816120 |
35 | oxidative phosphorylation (GO:0006119) | 4.00834183 |
36 | electron transport chain (GO:0022900) | 4.00454425 |
37 | muscle organ morphogenesis (GO:0048644) | 3.91690675 |
38 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.91029438 |
39 | regulation of cilium movement (GO:0003352) | 3.90643656 |
40 | regulation of translation in response to stress (GO:0043555) | 3.85572022 |
41 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.84027090 |
42 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.82543689 |
43 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.82543689 |
44 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.82176289 |
45 | mitotic sister chromatid segregation (GO:0000070) | 3.82087692 |
46 | protein targeting to mitochondrion (GO:0006626) | 3.78430967 |
47 | viral transcription (GO:0019083) | 3.75025131 |
48 | negative regulation of telomere maintenance (GO:0032205) | 3.74105826 |
49 | proteasome assembly (GO:0043248) | 3.73800633 |
50 | cullin deneddylation (GO:0010388) | 3.73105364 |
51 | DNA damage response, detection of DNA damage (GO:0042769) | 3.66346690 |
52 | pseudouridine synthesis (GO:0001522) | 3.65781195 |
53 | GDP-mannose metabolic process (GO:0019673) | 3.65241120 |
54 | histone H4-K5 acetylation (GO:0043981) | 3.64385370 |
55 | histone H4-K8 acetylation (GO:0043982) | 3.64385370 |
56 | coenzyme catabolic process (GO:0009109) | 3.62972234 |
57 | ribosomal small subunit assembly (GO:0000028) | 3.62084877 |
58 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.61715426 |
59 | chaperone-mediated protein transport (GO:0072321) | 3.58476788 |
60 | cytidine deamination (GO:0009972) | 3.58226882 |
61 | cytidine metabolic process (GO:0046087) | 3.58226882 |
62 | cytidine catabolic process (GO:0006216) | 3.58226882 |
63 | interferon-gamma production (GO:0032609) | 3.57915019 |
64 | translational termination (GO:0006415) | 3.57255302 |
65 | nucleoside transmembrane transport (GO:1901642) | 3.55097395 |
66 | heterochromatin organization (GO:0070828) | 3.53820789 |
67 | protein complex biogenesis (GO:0070271) | 3.51088129 |
68 | establishment of protein localization to mitochondrion (GO:0072655) | 3.48424634 |
69 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.47707796 |
70 | protein localization to chromosome, centromeric region (GO:0071459) | 3.47370134 |
71 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.46111679 |
72 | protein deneddylation (GO:0000338) | 3.43867482 |
73 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.43534675 |
74 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.43469207 |
75 | ribosome biogenesis (GO:0042254) | 3.43438298 |
76 | respiratory chain complex IV assembly (GO:0008535) | 3.42446805 |
77 | ribosomal large subunit biogenesis (GO:0042273) | 3.42141304 |
78 | maturation of SSU-rRNA (GO:0030490) | 3.41711534 |
79 | COPI coating of Golgi vesicle (GO:0048205) | 3.40413337 |
80 | Golgi transport vesicle coating (GO:0048200) | 3.40413337 |
81 | negative regulation of ligase activity (GO:0051352) | 3.40177629 |
82 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.40177629 |
83 | regulation of translational fidelity (GO:0006450) | 3.39451828 |
84 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.37609913 |
85 | NADH metabolic process (GO:0006734) | 3.37302673 |
86 | tricarboxylic acid cycle (GO:0006099) | 3.34277342 |
87 | protein localization to mitochondrion (GO:0070585) | 3.33691013 |
88 | notochord development (GO:0030903) | 3.32397941 |
89 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.31050274 |
90 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.30700362 |
91 | folic acid metabolic process (GO:0046655) | 3.30475783 |
92 | proline biosynthetic process (GO:0006561) | 3.30321341 |
93 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.29404880 |
94 | phenol-containing compound catabolic process (GO:0019336) | 3.29007325 |
95 | primary alcohol catabolic process (GO:0034310) | 3.28897279 |
96 | cytochrome complex assembly (GO:0017004) | 3.28647067 |
97 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.27009200 |
98 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.26764251 |
99 | L-phenylalanine metabolic process (GO:0006558) | 3.26764251 |
100 | cotranslational protein targeting to membrane (GO:0006613) | 3.25235772 |
101 | cellular component biogenesis (GO:0044085) | 3.24729339 |
102 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.24412193 |
103 | protein targeting to ER (GO:0045047) | 3.23655934 |
104 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.19740372 |
105 | DNA strand elongation (GO:0022616) | 3.17048704 |
106 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.16116648 |
107 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.14529620 |
108 | hormone catabolic process (GO:0042447) | 3.13954751 |
109 | response to dietary excess (GO:0002021) | 3.13098631 |
110 | chromatin assembly (GO:0031497) | 3.12147305 |
111 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.11932382 |
112 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.11932382 |
113 | nuclear envelope reassembly (GO:0031468) | 3.11424824 |
114 | mitotic nuclear envelope reassembly (GO:0007084) | 3.11424824 |
115 | ribosome assembly (GO:0042255) | 3.10326162 |
116 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.09522586 |
117 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.09030216 |
118 | termination of RNA polymerase III transcription (GO:0006386) | 3.09030216 |
119 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.08903844 |
120 | NADH dehydrogenase complex assembly (GO:0010257) | 3.08903844 |
121 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.08903844 |
122 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.07958534 |
123 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.07958534 |
124 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.07958534 |
125 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.07692405 |
126 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.07692405 |
127 | primitive streak formation (GO:0090009) | 3.07309186 |
128 | establishment of integrated proviral latency (GO:0075713) | 3.06129442 |
129 | tRNA aminoacylation for protein translation (GO:0006418) | 3.06017116 |
130 | protein localization to endoplasmic reticulum (GO:0070972) | 3.05698328 |
131 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.05129565 |
132 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.04505253 |
133 | mitochondrial transport (GO:0006839) | 3.03695623 |
134 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.01521527 |
135 | tRNA aminoacylation (GO:0043039) | 3.00583406 |
136 | amino acid activation (GO:0043038) | 3.00583406 |
137 | nuclear pore complex assembly (GO:0051292) | 2.98453994 |
138 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.98132837 |
139 | translational elongation (GO:0006414) | 2.97734405 |
140 | peptidyl-histidine modification (GO:0018202) | 2.97362053 |
141 | sister chromatid segregation (GO:0000819) | 2.95893463 |
142 | positive regulation of ligase activity (GO:0051351) | 2.95698371 |
143 | aerobic respiration (GO:0009060) | 2.94989448 |
144 | GTP biosynthetic process (GO:0006183) | 2.93367060 |
145 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.93307400 |
146 | UTP biosynthetic process (GO:0006228) | 2.92251355 |
147 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.90174835 |
148 | regulation of gene silencing by miRNA (GO:0060964) | 2.90174835 |
149 | regulation of gene silencing by RNA (GO:0060966) | 2.90174835 |
150 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.88309914 |
151 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.87932538 |
152 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.87190860 |
153 | regulation of telomerase activity (GO:0051972) | 2.85839028 |
154 | viral life cycle (GO:0019058) | 2.85082108 |
155 | cardiovascular system development (GO:0072358) | 2.80063639 |
156 | DNA replication initiation (GO:0006270) | 2.78660440 |
157 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.78094869 |
158 | translational initiation (GO:0006413) | 2.77472251 |
159 | transcription from mitochondrial promoter (GO:0006390) | 2.75754902 |
160 | rRNA processing (GO:0006364) | 2.74864247 |
161 | intestinal epithelial cell development (GO:0060576) | 2.73232145 |
162 | cellular modified amino acid catabolic process (GO:0042219) | 2.72824229 |
163 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.71395310 |
164 | positive regulation of defense response to virus by host (GO:0002230) | 2.71209089 |
165 | * translation (GO:0006412) | 2.69909811 |
166 | negative regulation of interleukin-2 production (GO:0032703) | 2.66267314 |
167 | mitochondrial DNA replication (GO:0006264) | 2.65639102 |
168 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.65109459 |
169 | nuclear pore organization (GO:0006999) | 2.65014530 |
170 | cellular protein complex disassembly (GO:0043624) | 2.63445343 |
171 | rRNA metabolic process (GO:0016072) | 2.63272301 |
172 | transcription from RNA polymerase I promoter (GO:0006360) | 2.62513007 |
173 | nucleoside transport (GO:0015858) | 2.62285521 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.19278986 |
2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.81065814 |
3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.81065814 |
4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.81065814 |
5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.81011229 |
6 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.17410728 |
7 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.09334546 |
8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.91327601 |
9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.75288691 |
10 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.53220566 |
11 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.50591094 |
12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.50036648 |
13 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.49576043 |
14 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.36750253 |
15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.33578867 |
16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.32905267 |
17 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.28532478 |
18 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.27387443 |
19 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.27112873 |
20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.26452704 |
21 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.26118342 |
22 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.22687336 |
23 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.19109918 |
24 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.18985095 |
25 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.15301914 |
26 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.13745662 |
27 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.99562115 |
28 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.99478622 |
29 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.98911694 |
30 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.95414846 |
31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.89478188 |
32 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.86325701 |
33 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.85176704 |
34 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.82112539 |
35 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.80775057 |
36 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.80736465 |
37 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.77997993 |
38 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.77912932 |
39 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.77855545 |
40 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.70806606 |
41 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.68932597 |
42 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.67776189 |
43 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.67009200 |
44 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66830973 |
45 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.66268615 |
46 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.65207943 |
47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.64158057 |
48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61865030 |
49 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.61034991 |
50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59232917 |
51 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.57043120 |
52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.53292244 |
53 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.49972716 |
54 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.46992344 |
55 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.45576279 |
56 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.44482229 |
57 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44274550 |
58 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.44044441 |
59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41469601 |
60 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.39672673 |
61 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.39081048 |
62 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.37366652 |
63 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34065108 |
64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.32991863 |
65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32499297 |
66 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.31574699 |
67 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30937648 |
68 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.30202534 |
69 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.29542998 |
70 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28685797 |
71 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.28395188 |
72 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.26890698 |
73 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.25483447 |
74 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.25409414 |
75 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.23877199 |
76 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.22951925 |
77 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.21357215 |
78 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.20536814 |
79 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.19164527 |
80 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.18884912 |
81 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.18708443 |
82 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.18019729 |
83 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.16692014 |
84 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.15959185 |
85 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.15260077 |
86 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.13906641 |
87 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.13691320 |
88 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.13364923 |
89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13201583 |
90 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.11463075 |
91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11347981 |
92 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.10571860 |
93 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.09918824 |
94 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.09047628 |
95 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.08862817 |
96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08602936 |
97 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.08186205 |
98 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.07092660 |
99 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07064870 |
100 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.05853467 |
101 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05281586 |
102 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.04264077 |
103 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04238313 |
104 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04157383 |
105 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.04003994 |
106 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.03921355 |
107 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.00870361 |
108 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.00531361 |
109 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00397915 |
110 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.00010450 |
111 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.99584197 |
112 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98723353 |
113 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.97776530 |
114 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.97672787 |
115 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.97137923 |
116 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96993398 |
117 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96358173 |
118 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.96230781 |
119 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.96222088 |
120 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95646913 |
121 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94852194 |
122 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94527866 |
123 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94522211 |
124 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93672955 |
125 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.93412735 |
126 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.93090748 |
127 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92514600 |
128 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90641218 |
129 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.89955618 |
130 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.86731045 |
131 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86536827 |
132 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.86301437 |
133 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.84518947 |
134 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.84387207 |
135 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.84203182 |
136 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.83648428 |
137 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.83300755 |
138 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.81567323 |
139 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.81446530 |
140 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.81100875 |
141 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80348194 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003011_delayed_dark_adaptation | 4.87685538 |
2 | MP0002254_reproductive_system_inflammat | 4.12870496 |
3 | MP0004264_abnormal_extraembryonic_tissu | 4.04026350 |
4 | MP0006292_abnormal_olfactory_placode | 4.02682442 |
5 | MP0005075_abnormal_melanosome_morpholog | 3.71971305 |
6 | MP0008057_abnormal_DNA_replication | 3.45900194 |
7 | MP0004957_abnormal_blastocyst_morpholog | 3.35495020 |
8 | MP0002877_abnormal_melanocyte_morpholog | 2.69514878 |
9 | MP0003890_abnormal_embryonic-extraembry | 2.62398423 |
10 | MP0004233_abnormal_muscle_weight | 2.57131721 |
11 | MP0005394_taste/olfaction_phenotype | 2.47947566 |
12 | MP0005499_abnormal_olfactory_system | 2.47947566 |
13 | MP0006035_abnormal_mitochondrial_morpho | 2.38453226 |
14 | MP0005408_hypopigmentation | 2.37924526 |
15 | MP0002332_abnormal_exercise_endurance | 2.35925400 |
16 | MP0001661_extended_life_span | 2.35601919 |
17 | MP0005451_abnormal_body_composition | 2.33144619 |
18 | MP0005171_absent_coat_pigmentation | 2.20746996 |
19 | MP0002277_abnormal_respiratory_mucosa | 2.14223251 |
20 | MP0003806_abnormal_nucleotide_metabolis | 2.09910087 |
21 | MP0004381_abnormal_hair_follicle | 2.08235727 |
22 | MP0005058_abnormal_lysosome_morphology | 2.06548267 |
23 | MP0000749_muscle_degeneration | 2.01028345 |
24 | MP0003077_abnormal_cell_cycle | 1.98114184 |
25 | MP0005330_cardiomyopathy | 1.96377490 |
26 | MP0000751_myopathy | 1.89868521 |
27 | MP0000678_abnormal_parathyroid_gland | 1.89000688 |
28 | MP0003693_abnormal_embryo_hatching | 1.88368422 |
29 | MP0000750_abnormal_muscle_regeneration | 1.79967458 |
30 | MP0006082_CNS_inflammation | 1.76040052 |
31 | MP0009840_abnormal_foam_cell | 1.73866739 |
32 | MP0002132_abnormal_respiratory_system | 1.72935430 |
33 | MP0002396_abnormal_hematopoietic_system | 1.71679974 |
34 | MP0005332_abnormal_amino_acid | 1.70745829 |
35 | MP0010094_abnormal_chromosome_stability | 1.68626900 |
36 | MP0003186_abnormal_redox_activity | 1.66249078 |
37 | MP0003111_abnormal_nucleus_morphology | 1.63774024 |
38 | MP0001853_heart_inflammation | 1.55518790 |
39 | MP0005670_abnormal_white_adipose | 1.52830655 |
40 | MP0005380_embryogenesis_phenotype | 1.51689075 |
41 | MP0001672_abnormal_embryogenesis/_devel | 1.51689075 |
42 | MP0003938_abnormal_ear_development | 1.48845135 |
43 | MP0003121_genomic_imprinting | 1.48212762 |
44 | MP0001764_abnormal_homeostasis | 1.47120145 |
45 | MP0005266_abnormal_metabolism | 1.46360565 |
46 | MP0006036_abnormal_mitochondrial_physio | 1.45520741 |
47 | MP0005083_abnormal_biliary_tract | 1.45127027 |
48 | MP0002653_abnormal_ependyma_morphology | 1.43400908 |
49 | MP0005257_abnormal_intraocular_pressure | 1.42803882 |
50 | MP0009379_abnormal_foot_pigmentation | 1.42727338 |
51 | MP0001881_abnormal_mammary_gland | 1.42643582 |
52 | MP0005501_abnormal_skin_physiology | 1.41889913 |
53 | MP0000350_abnormal_cell_proliferation | 1.39251441 |
54 | MP0000003_abnormal_adipose_tissue | 1.38146977 |
55 | MP0000747_muscle_weakness | 1.37368438 |
56 | MP0003950_abnormal_plasma_membrane | 1.36910108 |
57 | MP0000490_abnormal_crypts_of | 1.35985101 |
58 | MP0002088_abnormal_embryonic_growth/wei | 1.35555343 |
59 | MP0003984_embryonic_growth_retardation | 1.34907660 |
60 | MP0003122_maternal_imprinting | 1.34806287 |
61 | MP0009697_abnormal_copulation | 1.33923545 |
62 | MP0003136_yellow_coat_color | 1.33091425 |
63 | MP0008932_abnormal_embryonic_tissue | 1.32203225 |
64 | MP0008058_abnormal_DNA_repair | 1.29359159 |
65 | MP0005360_urolithiasis | 1.29233001 |
66 | MP0002127_abnormal_cardiovascular_syste | 1.29158371 |
67 | MP0002269_muscular_atrophy | 1.28206423 |
68 | MP0010352_gastrointestinal_tract_polyps | 1.24645792 |
69 | MP0004133_heterotaxia | 1.23841657 |
70 | MP0001293_anophthalmia | 1.23699039 |
71 | MP0003315_abnormal_perineum_morphology | 1.22200252 |
72 | MP0000759_abnormal_skeletal_muscle | 1.21131022 |
73 | MP0010234_abnormal_vibrissa_follicle | 1.20966590 |
74 | MP0002139_abnormal_hepatobiliary_system | 1.20114997 |
75 | MP0000762_abnormal_tongue_morphology | 1.19251862 |
76 | MP0009333_abnormal_splenocyte_physiolog | 1.17419729 |
77 | MP0004185_abnormal_adipocyte_glucose | 1.17075312 |
78 | MP0008438_abnormal_cutaneous_collagen | 1.15896055 |
79 | MP0005379_endocrine/exocrine_gland_phen | 1.14566994 |
80 | MP0005365_abnormal_bile_salt | 1.14031604 |
81 | MP0005165_increased_susceptibility_to | 1.12597897 |
82 | MP0003786_premature_aging | 1.11686908 |
83 | MP0008789_abnormal_olfactory_epithelium | 1.11609906 |
84 | MP0004043_abnormal_pH_regulation | 1.10758418 |
85 | MP0008007_abnormal_cellular_replicative | 1.09690753 |
86 | MP0000313_abnormal_cell_death | 1.08229202 |
87 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.08002098 |
88 | MP0004858_abnormal_nervous_system | 1.06125692 |
89 | MP0000013_abnormal_adipose_tissue | 1.05621376 |
90 | MP0002163_abnormal_gland_morphology | 1.04021770 |
91 | MP0003183_abnormal_peptide_metabolism | 1.02516444 |
92 | MP0002092_abnormal_eye_morphology | 1.02474339 |
93 | MP0002060_abnormal_skin_morphology | 1.00061234 |
94 | MP0001849_ear_inflammation | 0.97717494 |
95 | MP0000015_abnormal_ear_pigmentation | 0.97676687 |
96 | MP0001730_embryonic_growth_arrest | 0.96095268 |
97 | MP0002086_abnormal_extraembryonic_tissu | 0.94300222 |
98 | MP0000049_abnormal_middle_ear | 0.93695968 |
99 | MP0002085_abnormal_embryonic_tissue | 0.93370742 |
100 | MP0001727_abnormal_embryo_implantation | 0.92957819 |
101 | MP0003123_paternal_imprinting | 0.92915624 |
102 | MP0005623_abnormal_meninges_morphology | 0.92607117 |
103 | MP0000371_diluted_coat_color | 0.91824395 |
104 | MP0002098_abnormal_vibrissa_morphology | 0.91621265 |
105 | MP0000343_altered_response_to | 0.91530720 |
106 | MP0005375_adipose_tissue_phenotype | 0.89539956 |
107 | MP0005636_abnormal_mineral_homeostasis | 0.87107538 |
108 | MP0001186_pigmentation_phenotype | 0.86199291 |
109 | MP0000627_abnormal_mammary_gland | 0.85413895 |
110 | MP0009643_abnormal_urine_homeostasis | 0.85348052 |
111 | MP0000609_abnormal_liver_physiology | 0.84668628 |
112 | MP0002019_abnormal_tumor_incidence | 0.84343329 |
113 | MP0004147_increased_porphyrin_level | 0.84211061 |
114 | MP0002722_abnormal_immune_system | 0.83247784 |
115 | MP0008875_abnormal_xenobiotic_pharmacok | 0.83212868 |
116 | MP0000689_abnormal_spleen_morphology | 0.81249065 |
117 | MP0001905_abnormal_dopamine_level | 0.80877790 |
118 | MP0002970_abnormal_white_adipose | 0.80805351 |
119 | MP0004087_abnormal_muscle_fiber | 0.79491973 |
120 | MP0002932_abnormal_joint_morphology | 0.79359320 |
121 | MP0005671_abnormal_response_to | 0.78734922 |
122 | MP0001835_abnormal_antigen_presentation | 0.78451859 |
123 | MP0003718_maternal_effect | 0.78243925 |
124 | MP0005666_abnormal_adipose_tissue | 0.78171831 |
125 | MP0003191_abnormal_cellular_cholesterol | 0.76628789 |
126 | MP0005319_abnormal_enzyme/_coenzyme | 0.76389154 |
127 | MP0004782_abnormal_surfactant_physiolog | 0.75433413 |
128 | MP0002080_prenatal_lethality | 0.74523559 |
129 | MP0001216_abnormal_epidermal_layer | 0.74226077 |
130 | MP0008260_abnormal_autophagy | 0.74223885 |
131 | MP0009765_abnormal_xenobiotic_induced | 0.73388091 |
132 | MP0001243_abnormal_dermal_layer | 0.73333628 |
133 | MP0002095_abnormal_skin_pigmentation | 0.73169221 |
134 | MP0003656_abnormal_erythrocyte_physiolo | 0.72501989 |
135 | MP0002084_abnormal_developmental_patter | 0.71543191 |
136 | MP0000372_irregular_coat_pigmentation | 0.71440747 |
137 | MP0005376_homeostasis/metabolism_phenot | 0.70597904 |
138 | MP0010771_integument_phenotype | 0.70304788 |
139 | MP0003959_abnormal_lean_body | 0.70177444 |
140 | MP0001697_abnormal_embryo_size | 0.70047469 |
141 | MP0002075_abnormal_coat/hair_pigmentati | 0.69518081 |
142 | MP0002160_abnormal_reproductive_system | 0.69515549 |
143 | MP0000858_altered_metastatic_potential | 0.69486258 |
144 | MP0002429_abnormal_blood_cell | 0.69098967 |
145 | MP0000358_abnormal_cell_content/ | 0.69087933 |
146 | MP0001800_abnormal_humoral_immune | 0.68913639 |
147 | MP0000383_abnormal_hair_follicle | 0.68543189 |
148 | MP0003763_abnormal_thymus_physiology | 0.67224683 |
149 | MP0002114_abnormal_axial_skeleton | 0.66926783 |
150 | MP0005391_vision/eye_phenotype | 0.66485507 |
151 | MP0010030_abnormal_orbit_morphology | 0.65385547 |
152 | MP0008873_increased_physiological_sensi | 0.65328300 |
153 | MP0002796_impaired_skin_barrier | 0.64948413 |
154 | MP0000377_abnormal_hair_follicle | 0.63737519 |
155 | MP0008961_abnormal_basal_metabolism | 0.63554033 |
156 | MP0000432_abnormal_head_morphology | 0.63522636 |
157 | MP0005025_abnormal_response_to | 0.63299678 |
158 | MP0003705_abnormal_hypodermis_morpholog | 0.63296556 |
159 | MP0002405_respiratory_system_inflammati | 0.62577773 |
160 | MP0002233_abnormal_nose_morphology | 0.61935351 |
161 | MP0005023_abnormal_wound_healing | 0.60316733 |
162 | MP0001145_abnormal_male_reproductive | 0.59973136 |
163 | MP0000716_abnormal_immune_system | 0.59716327 |
164 | MP0002938_white_spotting | 0.59515574 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Bilateral microphthalmos (HP:0007633) | 6.00924537 |
2 | Multiple enchondromatosis (HP:0005701) | 5.74103666 |
3 | Hypochromic microcytic anemia (HP:0004840) | 5.11541511 |
4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.04035119 |
5 | Acute necrotizing encephalopathy (HP:0006965) | 4.96959496 |
6 | Acute encephalopathy (HP:0006846) | 4.69474883 |
7 | Mitochondrial inheritance (HP:0001427) | 4.66670638 |
8 | Hepatocellular necrosis (HP:0001404) | 4.44834392 |
9 | Hepatic necrosis (HP:0002605) | 4.34115825 |
10 | Increased CSF lactate (HP:0002490) | 4.28784317 |
11 | Increased intramyocellular lipid droplets (HP:0012240) | 4.11276768 |
12 | Progressive macrocephaly (HP:0004481) | 4.01106529 |
13 | Rib fusion (HP:0000902) | 3.86093448 |
14 | Increased muscle lipid content (HP:0009058) | 3.83556238 |
15 | Increased hepatocellular lipid droplets (HP:0006565) | 3.80208811 |
16 | Cerebral edema (HP:0002181) | 3.72156733 |
17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.70565173 |
18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.70565173 |
19 | Lipid accumulation in hepatocytes (HP:0006561) | 3.66410652 |
20 | Hepatoblastoma (HP:0002884) | 3.61644587 |
21 | Ependymoma (HP:0002888) | 3.60807477 |
22 | Reduced antithrombin III activity (HP:0001976) | 3.56967480 |
23 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.56625268 |
24 | Exercise intolerance (HP:0003546) | 3.56258385 |
25 | 3-Methylglutaconic aciduria (HP:0003535) | 3.46646790 |
26 | Chromsome breakage (HP:0040012) | 3.42689238 |
27 | Rhabdomyosarcoma (HP:0002859) | 3.42619996 |
28 | Lactic acidosis (HP:0003128) | 3.36895792 |
29 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.36845305 |
30 | Increased serum lactate (HP:0002151) | 3.33996696 |
31 | Partial duplication of thumb phalanx (HP:0009944) | 3.33909673 |
32 | Hypoplasia of the fovea (HP:0007750) | 3.32517492 |
33 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.32517492 |
34 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.31219413 |
35 | Testicular atrophy (HP:0000029) | 3.18245875 |
36 | Neoplasm of striated muscle (HP:0009728) | 3.16636774 |
37 | Trismus (HP:0000211) | 3.12977290 |
38 | Embryonal renal neoplasm (HP:0011794) | 3.07757976 |
39 | Abnormal lung lobation (HP:0002101) | 3.06869047 |
40 | Rectovaginal fistula (HP:0000143) | 3.06814896 |
41 | Rectal fistula (HP:0100590) | 3.06814896 |
42 | Respiratory failure (HP:0002878) | 3.06479746 |
43 | Microvesicular hepatic steatosis (HP:0001414) | 3.03915625 |
44 | Abnormality of the salivary glands (HP:0010286) | 3.03839583 |
45 | Type I transferrin isoform profile (HP:0003642) | 2.97402026 |
46 | Aplastic anemia (HP:0001915) | 2.94714177 |
47 | Ragged-red muscle fibers (HP:0003200) | 2.89010398 |
48 | Anomalous pulmonary venous return (HP:0010772) | 2.88632285 |
49 | Fused cervical vertebrae (HP:0002949) | 2.87956384 |
50 | Abnormal hemoglobin (HP:0011902) | 2.86424959 |
51 | Abnormal cartilage morphology (HP:0002763) | 2.85994781 |
52 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.85606163 |
53 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.83605466 |
54 | Partial duplication of the phalanx of hand (HP:0009999) | 2.83086728 |
55 | Abnormality of the lower motor neuron (HP:0002366) | 2.82328051 |
56 | Hypochromic anemia (HP:0001931) | 2.79122091 |
57 | Cholecystitis (HP:0001082) | 2.77126643 |
58 | Abnormal gallbladder physiology (HP:0012438) | 2.77126643 |
59 | Abnormality of glycolysis (HP:0004366) | 2.75423787 |
60 | Increased serum pyruvate (HP:0003542) | 2.75423787 |
61 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.72875665 |
62 | Vertebral compression fractures (HP:0002953) | 2.71198628 |
63 | Rhabdomyolysis (HP:0003201) | 2.67659862 |
64 | Respiratory difficulties (HP:0002880) | 2.63180549 |
65 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.63127899 |
66 | Hypokinesia (HP:0002375) | 2.63126747 |
67 | Vaginal fistula (HP:0004320) | 2.62995936 |
68 | Nasolacrimal duct obstruction (HP:0000579) | 2.61928817 |
69 | Intestinal fistula (HP:0100819) | 2.57785134 |
70 | Abnormal number of erythroid precursors (HP:0012131) | 2.54273143 |
71 | Bifid tongue (HP:0010297) | 2.52941791 |
72 | Abnormality of the fovea (HP:0000493) | 2.51064228 |
73 | Meckel diverticulum (HP:0002245) | 2.50201457 |
74 | Combined immunodeficiency (HP:0005387) | 2.49267099 |
75 | Supernumerary spleens (HP:0009799) | 2.49071278 |
76 | Microretrognathia (HP:0000308) | 2.48976676 |
77 | Abnormality of the pulmonary veins (HP:0011718) | 2.47228383 |
78 | Abnormality of placental membranes (HP:0011409) | 2.40891552 |
79 | Amniotic constriction ring (HP:0009775) | 2.40891552 |
80 | Abnormality of the ileum (HP:0001549) | 2.38668966 |
81 | Lethargy (HP:0001254) | 2.36814750 |
82 | Myoglobinuria (HP:0002913) | 2.36270758 |
83 | Premature ovarian failure (HP:0008209) | 2.35977677 |
84 | Esophageal neoplasm (HP:0100751) | 2.35095855 |
85 | Neoplasm of head and neck (HP:0012288) | 2.35095855 |
86 | Progressive muscle weakness (HP:0003323) | 2.34102155 |
87 | Impulsivity (HP:0100710) | 2.32302529 |
88 | Sensory axonal neuropathy (HP:0003390) | 2.31518210 |
89 | Rough bone trabeculation (HP:0100670) | 2.30889180 |
90 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.28567705 |
91 | Renal Fanconi syndrome (HP:0001994) | 2.25821012 |
92 | Cheilitis (HP:0100825) | 2.25545668 |
93 | Spastic paraparesis (HP:0002313) | 2.25053115 |
94 | Reticulocytopenia (HP:0001896) | 2.24555168 |
95 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.24057619 |
96 | Leukodystrophy (HP:0002415) | 2.23609174 |
97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.21710273 |
98 | Dicarboxylic aciduria (HP:0003215) | 2.21710273 |
99 | Glossoptosis (HP:0000162) | 2.20254221 |
100 | Progressive external ophthalmoplegia (HP:0000590) | 2.20198768 |
101 | CNS demyelination (HP:0007305) | 2.19763293 |
102 | Hyperammonemia (HP:0001987) | 2.18877591 |
103 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.18143997 |
104 | Villous atrophy (HP:0011473) | 2.18143997 |
105 | Generalized aminoaciduria (HP:0002909) | 2.16300782 |
106 | Exertional dyspnea (HP:0002875) | 2.16209683 |
107 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.15047984 |
108 | Sparse eyelashes (HP:0000653) | 2.14215247 |
109 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.11785347 |
110 | Cholelithiasis (HP:0001081) | 2.10024706 |
111 | Opisthotonus (HP:0002179) | 2.08071346 |
112 | Emotional lability (HP:0000712) | 2.07899278 |
113 | Pallor (HP:0000980) | 2.06430837 |
114 | Abnormality of the intrinsic pathway (HP:0010989) | 2.05246304 |
115 | Pendular nystagmus (HP:0012043) | 2.05179057 |
116 | Secondary amenorrhea (HP:0000869) | 2.02693634 |
117 | Nasal polyposis (HP:0100582) | 2.01933929 |
118 | Preauricular skin tag (HP:0000384) | 2.00687220 |
119 | Horizontal nystagmus (HP:0000666) | 2.00193127 |
120 | Short humerus (HP:0005792) | 1.97247077 |
121 | Abnormality of the anterior horn cell (HP:0006802) | 1.96815349 |
122 | Degeneration of anterior horn cells (HP:0002398) | 1.96815349 |
123 | Malnutrition (HP:0004395) | 1.96732607 |
124 | Tongue fasciculations (HP:0001308) | 1.93521682 |
125 | Pancytopenia (HP:0001876) | 1.92875154 |
126 | Duplication of thumb phalanx (HP:0009942) | 1.90571310 |
127 | Duodenal stenosis (HP:0100867) | 1.90536693 |
128 | Small intestinal stenosis (HP:0012848) | 1.90536693 |
129 | Periauricular skin pits (HP:0100277) | 1.89159314 |
130 | Preauricular pit (HP:0004467) | 1.89159314 |
131 | Macrocytic anemia (HP:0001972) | 1.89141611 |
132 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.88594685 |
133 | Cerebral hypomyelination (HP:0006808) | 1.88430739 |
134 | Abnormality of renal resorption (HP:0011038) | 1.88402959 |
135 | Abnormality of the preputium (HP:0100587) | 1.87851937 |
136 | Facial cleft (HP:0002006) | 1.87814226 |
137 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.87439465 |
138 | Abnormal gallbladder morphology (HP:0012437) | 1.87410810 |
139 | Generalized amyotrophy (HP:0003700) | 1.84882309 |
140 | Myelodysplasia (HP:0002863) | 1.84442644 |
141 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.83401953 |
142 | Large earlobe (HP:0009748) | 1.82856076 |
143 | Abnormal protein glycosylation (HP:0012346) | 1.82140118 |
144 | Abnormal glycosylation (HP:0012345) | 1.82140118 |
145 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.82140118 |
146 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.82140118 |
147 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.81767124 |
148 | Abnormality of the astrocytes (HP:0100707) | 1.80510343 |
149 | Astrocytoma (HP:0009592) | 1.80510343 |
150 | Abnormality of methionine metabolism (HP:0010901) | 1.79470519 |
151 | Abnormality of the lacrimal duct (HP:0011481) | 1.79436979 |
152 | Gout (HP:0001997) | 1.78563709 |
153 | Cleft eyelid (HP:0000625) | 1.77667078 |
154 | Cutaneous melanoma (HP:0012056) | 1.77547470 |
155 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.76597933 |
156 | Abnormal trabecular bone morphology (HP:0100671) | 1.76064339 |
157 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.74893642 |
158 | Hyperglycinuria (HP:0003108) | 1.74628857 |
159 | Upper motor neuron abnormality (HP:0002127) | 1.73984206 |
160 | Optic disc pallor (HP:0000543) | 1.73563519 |
161 | Distal lower limb muscle weakness (HP:0009053) | 1.71666266 |
162 | Myopathic facies (HP:0002058) | 1.71590892 |
163 | Vomiting (HP:0002013) | 1.71526308 |
164 | Exercise-induced myalgia (HP:0003738) | 1.69378958 |
165 | Unilateral renal agenesis (HP:0000122) | 1.68952667 |
166 | Oral leukoplakia (HP:0002745) | 1.68425418 |
167 | Abnormality of alanine metabolism (HP:0010916) | 1.68238149 |
168 | Hyperalaninemia (HP:0003348) | 1.68238149 |
169 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.68238149 |
170 | Squamous cell carcinoma (HP:0002860) | 1.67987283 |
171 | Entropion (HP:0000621) | 1.67186458 |
172 | Diminished movement (HP:0002374) | 1.65813191 |
173 | Abnormality of the umbilical cord (HP:0010881) | 1.62469032 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 6.76726838 |
2 | VRK2 | 4.81945413 |
3 | GRK5 | 4.42763388 |
4 | GRK6 | 3.99087146 |
5 | ERN1 | 3.77986785 |
6 | ADRBK2 | 3.38724676 |
7 | GRK7 | 3.02120818 |
8 | GRK1 | 2.99968644 |
9 | NEK1 | 2.89382499 |
10 | CSF1R | 2.86194941 |
11 | TTK | 2.83127029 |
12 | PDK2 | 2.54607518 |
13 | TGFBR2 | 2.46552140 |
14 | TESK1 | 2.45300786 |
15 | STK10 | 2.36584209 |
16 | MST1R | 2.14739013 |
17 | MAPK7 | 2.03359162 |
18 | MATK | 2.01134299 |
19 | SCYL2 | 1.89589065 |
20 | NME2 | 1.88593103 |
21 | MOS | 1.87750561 |
22 | LIMK1 | 1.87418335 |
23 | SMG1 | 1.80434114 |
24 | TYRO3 | 1.78303052 |
25 | CCNB1 | 1.78080403 |
26 | CDK7 | 1.69443722 |
27 | BUB1 | 1.64501611 |
28 | SRPK1 | 1.59357467 |
29 | EPHA2 | 1.54647582 |
30 | WEE1 | 1.52465692 |
31 | MST4 | 1.49219437 |
32 | ARAF | 1.47202505 |
33 | WNK1 | 1.45022656 |
34 | MAPKAPK3 | 1.44830280 |
35 | MAP2K6 | 1.39695429 |
36 | ILK | 1.39199358 |
37 | TRIB3 | 1.36310364 |
38 | PRKG2 | 1.35947025 |
39 | EIF2AK2 | 1.33693759 |
40 | PLK1 | 1.33098047 |
41 | ABL2 | 1.28029774 |
42 | CHEK2 | 1.26215555 |
43 | PHKG2 | 1.25075915 |
44 | PHKG1 | 1.25075915 |
45 | RPS6KB2 | 1.22655834 |
46 | BRSK1 | 1.12818796 |
47 | MAP3K12 | 1.11036238 |
48 | PAK4 | 1.09996363 |
49 | DAPK1 | 1.09631633 |
50 | EIF2AK1 | 1.08679718 |
51 | PRKD3 | 1.06693439 |
52 | ADRBK1 | 1.06499072 |
53 | BCKDK | 1.06341002 |
54 | STK16 | 0.99178452 |
55 | CDC7 | 0.97082350 |
56 | CAMK4 | 0.95443220 |
57 | AKT3 | 0.93309964 |
58 | TSSK6 | 0.93153362 |
59 | LRRK2 | 0.92941452 |
60 | LMTK2 | 0.87625070 |
61 | TLK1 | 0.87576669 |
62 | EIF2AK3 | 0.87280310 |
63 | PBK | 0.87171753 |
64 | IKBKB | 0.85402934 |
65 | TAOK2 | 0.84857018 |
66 | MARK2 | 0.83661182 |
67 | CSNK1G3 | 0.81384215 |
68 | DAPK3 | 0.80877152 |
69 | CSK | 0.79741356 |
70 | NEK2 | 0.78968625 |
71 | KDR | 0.77842296 |
72 | VRK1 | 0.77500097 |
73 | HIPK2 | 0.76992156 |
74 | SIK1 | 0.73438223 |
75 | CHEK1 | 0.71473589 |
76 | ICK | 0.71157203 |
77 | BLK | 0.70453935 |
78 | AURKA | 0.69931715 |
79 | CAMK2G | 0.69897432 |
80 | AURKB | 0.69561269 |
81 | MYLK | 0.67896379 |
82 | IRAK3 | 0.67770864 |
83 | FLT3 | 0.67513569 |
84 | IRAK4 | 0.67231539 |
85 | MUSK | 0.62235465 |
86 | MAP2K4 | 0.60348574 |
87 | MET | 0.59098093 |
88 | MAP3K8 | 0.58770119 |
89 | MAPKAPK5 | 0.58490719 |
90 | TESK2 | 0.58452506 |
91 | BRAF | 0.56668091 |
92 | AKT2 | 0.55205710 |
93 | CSNK1A1L | 0.54810735 |
94 | PLK3 | 0.53288398 |
95 | ACVR1B | 0.52729463 |
96 | PRKCI | 0.50610463 |
97 | STK4 | 0.50235336 |
98 | ERBB4 | 0.49077246 |
99 | DYRK3 | 0.48773926 |
100 | MAPK12 | 0.47586359 |
101 | TTN | 0.47408768 |
102 | ITK | 0.47081647 |
103 | MAP3K3 | 0.46553575 |
104 | RPS6KA5 | 0.45704000 |
105 | FGFR3 | 0.45680981 |
106 | ZAP70 | 0.44157813 |
107 | MAP3K11 | 0.44122052 |
108 | TAF1 | 0.43902084 |
109 | PTK2 | 0.43780131 |
110 | CDK4 | 0.43418347 |
111 | PIM2 | 0.42710056 |
112 | PAK1 | 0.42121054 |
113 | NUAK1 | 0.41350602 |
114 | CDK8 | 0.40325964 |
115 | MAP2K3 | 0.39593444 |
116 | KIT | 0.39557178 |
117 | PRKCD | 0.39374578 |
118 | CDK2 | 0.39015278 |
119 | RAF1 | 0.37630941 |
120 | NTRK1 | 0.36838527 |
121 | MAP4K1 | 0.36509783 |
122 | MAPK11 | 0.36250723 |
123 | CSNK1G1 | 0.35838594 |
124 | NME1 | 0.35343052 |
125 | NLK | 0.34342165 |
126 | ATM | 0.33921971 |
127 | CAMK2D | 0.33568864 |
128 | PIM1 | 0.31710758 |
129 | CDK9 | 0.31167917 |
130 | DYRK2 | 0.31019462 |
131 | EEF2K | 0.30782063 |
132 | BRSK2 | 0.30757318 |
133 | PASK | 0.30267266 |
134 | CSNK2A1 | 0.29303625 |
135 | OBSCN | 0.28953319 |
136 | TBK1 | 0.28725604 |
137 | IGF1R | 0.27921481 |
138 | MAP3K10 | 0.25971446 |
139 | CSNK2A2 | 0.25297047 |
140 | DMPK | 0.23907937 |
141 | MELK | 0.23864565 |
142 | RPS6KA4 | 0.23758757 |
143 | MAP2K2 | 0.23455989 |
144 | SIK3 | 0.23363572 |
145 | TYK2 | 0.23361548 |
146 | LCK | 0.23068001 |
147 | STK39 | 0.22649797 |
148 | YES1 | 0.22546449 |
149 | ATR | 0.21181393 |
150 | MAPK4 | 0.20776013 |
151 | MKNK1 | 0.20562947 |
152 | ZAK | 0.20321534 |
153 | PLK4 | 0.20105779 |
154 | MAP3K7 | 0.19117039 |
155 | ALK | 0.19033686 |
156 | CSNK1E | 0.18065791 |
157 | PDK3 | 0.17435862 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Ribosome_Homo sapiens_hsa03010 | 4.28993406 |
2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.04208856 |
3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.56443148 |
4 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.37235283 |
5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.94389912 |
6 | RNA polymerase_Homo sapiens_hsa03020 | 2.43298666 |
7 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.40088278 |
8 | DNA replication_Homo sapiens_hsa03030 | 2.39437910 |
9 | Proteasome_Homo sapiens_hsa03050 | 2.36690316 |
10 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.29153631 |
11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.28958679 |
12 | Mismatch repair_Homo sapiens_hsa03430 | 2.24494842 |
13 | Homologous recombination_Homo sapiens_hsa03440 | 2.17429515 |
14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.96250882 |
15 | RNA transport_Homo sapiens_hsa03013 | 1.83023263 |
16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.80679865 |
17 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.74626593 |
18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.72747805 |
19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.65891369 |
20 | Spliceosome_Homo sapiens_hsa03040 | 1.61886389 |
21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.59849649 |
22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.57384368 |
23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.56543648 |
24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.51323625 |
25 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.49488333 |
26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47878770 |
27 | Galactose metabolism_Homo sapiens_hsa00052 | 1.45075338 |
28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.42605601 |
29 | RNA degradation_Homo sapiens_hsa03018 | 1.41240068 |
30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.41182365 |
31 | Base excision repair_Homo sapiens_hsa03410 | 1.40968518 |
32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.40190744 |
33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.34316123 |
34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.31989702 |
35 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.31257770 |
36 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.30650381 |
37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19933371 |
38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17732660 |
39 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.10031983 |
40 | Huntingtons disease_Homo sapiens_hsa05016 | 1.06262735 |
41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.05001519 |
42 | Protein export_Homo sapiens_hsa03060 | 1.04751281 |
43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00265994 |
44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98210645 |
45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.97245284 |
46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97155675 |
47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93378863 |
48 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.93348361 |
49 | Cell cycle_Homo sapiens_hsa04110 | 0.91577436 |
50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91300957 |
51 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90440112 |
52 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.89944414 |
53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.89470491 |
54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.88831606 |
55 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88380910 |
56 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87271913 |
57 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86221058 |
58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83297696 |
59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83137593 |
60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82256336 |
61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.82216254 |
62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78872642 |
63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77829202 |
64 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75785339 |
65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74121666 |
66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.73516085 |
67 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72556639 |
68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72451046 |
69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69037672 |
70 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.68085969 |
71 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67031175 |
72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64318941 |
73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64157264 |
74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63836508 |
75 | Purine metabolism_Homo sapiens_hsa00230 | 0.63317088 |
76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61340313 |
77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60448020 |
78 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.60100303 |
79 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58893534 |
80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58625680 |
81 | Peroxisome_Homo sapiens_hsa04146 | 0.57740377 |
82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57437577 |
83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55672608 |
84 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.54187223 |
85 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52225055 |
86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50349449 |
87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49075745 |
88 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.48934020 |
89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48243748 |
90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46700354 |
91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45748474 |
92 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.44537016 |
93 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43352730 |
94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39589005 |
95 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39400583 |
96 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.38855705 |
97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33866074 |
98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32744653 |
99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32689230 |
100 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31809212 |
101 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.30688061 |
102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.30529880 |
103 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.28222596 |
104 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.27730791 |
105 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.27109413 |
106 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.24551543 |
107 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.23878916 |
108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.23833485 |
109 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.23239077 |
110 | Prion diseases_Homo sapiens_hsa05020 | 0.21980338 |
111 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.21590779 |
112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.20496865 |
113 | Apoptosis_Homo sapiens_hsa04210 | 0.20420667 |
114 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.20377092 |
115 | Bladder cancer_Homo sapiens_hsa05219 | 0.19464751 |
116 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.18642740 |
117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.17348429 |
118 | Lysosome_Homo sapiens_hsa04142 | 0.14958703 |
119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.14315376 |
120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14011449 |
121 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.13628341 |
122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.11623152 |
123 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.11157456 |
124 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.10149098 |